Concomitant Immunosuppressive Therapy and Eculizumab Use in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): An International PNH Registry Analysis

Hill, A; de Latour, RP; Kulasekararaj, AG; Griffin, M; Brodsky, RA; Maciejewski, JP; Marantz, JL; Gustovic, P; Schrezenmeier, H

Hill, A (通讯作者)，Alexion Pharm UK LTD, Global Med Affairs, 3 Furzeground Way,Stockley Pk, Uxbridge UB11 1EZ, Middlesex, England.

ACTA HAEMATOLOGICA, 2023; 146 (1):

Abstract

Introduction: Complement C5 inhibitor eculizumab is the first approved treatment for paroxysmal nocturnal hemoglobinuria (PNH), a rare hematologic dis......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索